Harbourvest Partners LLC Rallybio Corp Transaction History
Harbourvest Partners LLC
- $94.6 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
50Shares Held
32.7MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$1.13 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$981,8181.19% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$980,2951.55% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$891,4324.27% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$817,6710.08% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $8.68M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...